企業プロフィール
Sanofi 株価・ニュース・カタリスト
- ティッカー:
- SNY
- 取引所:
- NASDAQ
- セクター:
- Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
- 所在地:
- France and listed in the U
株価パフォーマンス
44.41 USD (+1.58%)
終値
最終更新: 2026年8月17日
102B USD
時価総額
株価変動の要因
As of Aug 17, 2026, SNY closed up 1.58% at $44.41. No new same-company headline was identified in the current news window.
企業概要
事業概要
Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.
所在地とセクター分類
Headquartered in France and listed in the U.S. as an ADR, Sanofi operates globally across Europe, the U.S., and other major markets. It is one of the largest international biopharma names.
ビジネスモデルの特徴
Sanofi combines product revenue with pipeline investment and portfolio restructuring. Investors focus on immunology growth, vaccine performance, and the company’s ability to keep improving its innovation mix.
バイオ業界での位置付け
Sanofi sits in the upper tier of global biopharma, where scale and pipeline quality matter more than single-stock binary events. It still reacts to major clinical and regulatory updates, especially in immunology and rare disease.
今後のカタリスト
- Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。